Cargando…
[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
Aims: Apelin is a predicted substrate for ACE2, a novel therapeutic target. Our aim was to demonstrate the endogenous presence of the putative ACE2 product [Pyr(1)]apelin-13((1–12)) in human cardiovascular tissues and to confirm it retains significant biological activity for the apelin receptor in v...
Autores principales: | Yang, Peiran, Kuc, Rhoda E., Brame, Aimée L., Dyson, Alex, Singer, Mervyn, Glen, Robert C., Cheriyan, Joseph, Wilkinson, Ian B., Davenport, Anthony P., Maguire, Janet J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329011/ https://www.ncbi.nlm.nih.gov/pubmed/28293165 http://dx.doi.org/10.3389/fnins.2017.00092 |
Ejemplares similares
-
Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019) -
Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist
por: Brame, Aimee L., et al.
Publicado: (2015) -
Systemic Outcomes of (Pyr(1))-Apelin-13 Infusion at Mid-Late Pregnancy in a Rat Model with Preeclamptic Features
por: Yamaleyeva, Liliya M., et al.
Publicado: (2019) -
Vasopressin V1a receptors mediate the hypertensive effects of [Pyr(1)]apelin‐13 in the rat rostral ventrolateral medulla
por: Griffiths, Philip R., et al.
Publicado: (2017) -
Prolyl Carboxypeptidase Mediates the C-Terminal Cleavage of (Pyr)-Apelin-13 in Human Umbilical Vein and Aortic Endothelial Cells
por: De Hert, Emilie, et al.
Publicado: (2021)